Latest News and Press Releases
Want to stay updated on the latest news?
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Revance Therapeutics, Inc....
-
Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm
-
Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm
-
LOS ANGELES, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) investors that the firm has initiated an...